EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Precision oncolytic viral therapy in colorectal cancer: Genetic targeting and immune modulation for personalized treatment (Review)

Muhammad Haris Sultan, Qi Zhan, Yigang Wang, Yulong Xia, Xiaoyuan Jia

International Journal of Molecular Medicine · 2025

DOI: 10.3892/ijmm.2025.5545 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Muhammad Haris Sultan und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Xinyuan Institute of Medicine and Biotechnology, Zhejiang Sci‑Tech University, Hangzhou, Zhejiang 310018, P.R.…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Oncolytic Virotherapy, Precision Medicine, Oncolytic Viruses. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 270 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a leading health issue and treatments to eradicate it, such as conventional chemotherapy, are non‑selective and come with a number of complications. The present review focuses on the relatively new area of precision oncolytic viral therapy (OVT), with genetic targeting and immune modifications that offer a new future for CRC treatment. In the present review, an overview of the selection factors that are considered optimal for an oncolytic virus, mechanisms of oncolysis and immunomodulation applied to the OVT, as well as new strategies to improve the efficacy of this method are described. Additionally, cause‑and‑effect relationships are examined for OVT efficacy, mediated by the tumor microenvironment, and directions for genetic manipulation of viral specificity are explored. The possibility of synergy between OVT and immune checkpoint inhibitors and other treatment approaches are demonstrated. Incorporating the details of the present review, biomarker‑guided combination therapies in precision OVT for individualized CRC care, significant issues and future trends in this required area of medicine are highlighted. Increasingly, OVT is leaving the experimental stage and may become routine practice; it provides a new perspective on overcoming CRC and highlights the importance of further research and clinical work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsOncolytic VirotherapyPrecision MedicineOncolytic VirusesGene TargetingImmunomodulationHumansTumor MicroenvironmentAnimalsImmunotherapy

Stichwörter der Autor:innen

biomarkerscolorectal cancerimmune modulationoncolytic viral therapypersonalized treatmentprecision medicine

Autor:innen und Institutionen

  • College of Life Sciences and Medicine, Xinyuan Institute of Medicine and Biotechnology, Zhejiang Sci‑Tech University, Hangzhou, Zhejiang 310018, P.R. China.
  • Center for Translational Medicine and Precision Medicine, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325000, P.R. China.

Zitieren

APA

Sultan, M. H., Zhan, Q., Wang, Y., Xia, Y., & Jia, X. (2025). Precision oncolytic viral therapy in colorectal cancer: Genetic targeting and immune modulation for personalized treatment (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5545

Vancouver

Sultan MH, Zhan Q, Wang Y, Xia Y, Jia X. Precision oncolytic viral therapy in colorectal cancer: Genetic targeting and immune modulation for personalized treatment (Review). International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5545

BibTeX
@article{Sultan2025,
  author = {Sultan, Muhammad Haris and Zhan, Qi and Wang, Yigang and Xia, Yulong and Jia, Xiaoyuan},
  title = {Precision oncolytic viral therapy in colorectal cancer: Genetic targeting and immune modulation for personalized treatment (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2025},
  doi = {10.3892/ijmm.2025.5545}
}
Kostenlos starten →